Literature DB >> 19631957

Down-regulation of multiple cell survival proteins in head and neck cancer cells by an apoptogenic mutant of adenovirus type 5.

S Vijayalingam1, T Subramanian, Jan Ryerse, Mark Varvares, G Chinnadurai.   

Abstract

Head and neck squamous cell carcinomas (HNSCC) are one of the leading causes of cancer deaths world wide. Up-regulation of the epidermal growth factor receptor (EGFR) and BCL-2 family anti-apoptosis proteins in these cancers is linked to aggressive tumor growth, metastasis and chemoresistance. Infection of two HNSCC cell lines, SCC25 and CAL27 by an Ad5 mutant (lp11w) defective in coding for the viral anti-apoptosis protein, E1B-19K efficiently induced apoptotic cell death. In cells infected with lp11w there was a dramatic down-regulation of EGFR by apoptosis-dependent and -independent mechanisms. The levels of the anti-apoptotic proteins BCL-2, BCL-xL and MCL-1 were also down-regulated in lp11w-infected cells compared to uninfected or Ad5-RM infected cells. Infection with lp11w also enhanced sensitivity of the HNSCC cells to the chemotherapeutic drug cisplatin. Our results suggest that adenoviral vectors defective in E1B-19K would be valuable for efficient down-regulation of cell survival proteins and EGFR in epithelial cancers and could be exploited as oncolytic agents to treat HNSCCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631957      PMCID: PMC2774264          DOI: 10.1016/j.virol.2009.06.048

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  A simple method for the rapid generation of recombinant adenovirus vectors.

Authors:  R D Anderson; R E Haskell; H Xia; B J Roessler; B L Davidson
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

2.  a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

Authors:  F R Khuri; J Nemunaitis; I Ganly; J Arseneau; I F Tannock; L Romel; M Gore; J Ironside; R H MacDougall; C Heise; B Randlev; A M Gillenwater; P Bruso; S B Kaye; W K Hong; D H Kirn
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 3.  Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection.

Authors:  Andrea Cuconati; Eileen White
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

4.  E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.

Authors:  Marcella Flinterman; Joop Gäken; Farzin Farzaneh; Mahvash Tavassoli
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

Review 5.  STAT signaling in head and neck cancer.

Authors:  J I Song; J R Grandis
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

6.  Proteolytic cleavage of epidermal growth factor receptor by caspases.

Authors:  S S Bae; J H Choi; Y S Oh; D K Perry; S H Ryu; P G Suh
Journal:  FEBS Lett       Date:  2001-02-23       Impact factor: 4.124

7.  Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.

Authors:  K Doronin; K Toth; M Kuppuswamy; P Ward; A E Tollefson; W S Wold
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector.

Authors:  H Sauthoff; S Heitner; W N Rom; J G Hay
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

9.  Downregulation of epidermal growth factor receptor signaling by singlet oxygen through activation of caspase-3 and protein phosphatases.

Authors:  Shougang Zhuang; Gladys D Ouedraogo; Irene E Kochevar
Journal:  Oncogene       Date:  2003-07-10       Impact factor: 9.867

Review 10.  STAT3 as a target for inducing apoptosis in solid and hematological tumors.

Authors:  Khandaker Al Zaid Siddiquee; James Turkson
Journal:  Cell Res       Date:  2008-02       Impact factor: 25.617

View more
  4 in total

1.  Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.

Authors:  Han Hsi Wong; Nicholas R Lemoine; Yaohe Wang
Journal:  Viruses       Date:  2010-01       Impact factor: 5.818

Review 2.  From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer.

Authors:  Carolina S Ilkow; Stephanie L Swift; John C Bell; Jean-Simon Diallo
Journal:  PLoS Pathog       Date:  2014-01-16       Impact factor: 6.823

3.  Cell-Surface Integrins and CAR Are Both Essential for Adenovirus Type 5 Transduction of Canine Cells of Lymphocytic Origin.

Authors:  Payal Agarwal; Elizabeth A Gammon; Abdul Mohin Sajib; Maninder Sandey; Bruce F Smith
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

4.  Evaluation of apoptogenic adenovirus type 5 oncolytic vectors in a Syrian hamster head and neck cancer model.

Authors:  S Vijayalingam; Mohan Kuppusamy; T Subramanian; Frank F Strebeck; Cheri L West; Mark Varvares; G Chinnadurai
Journal:  Cancer Gene Ther       Date:  2014-05-30       Impact factor: 5.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.